Physician profile
Larisa Kayserman
NPI 1417926361
$5,516.38
in general payments reported to CMS, 2019-2025
23 companies · $950 in 2025
The $950 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,224 · 2020: $934 · 2021: $410 · 2022: $329 · 2023: $776 · 2024: $894 · 2025: $950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,620.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $847.90 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $631.49 | 2022-2025 | Envista Mx60 Iol, Vyzulta, Miebo |
| Apellis Pharmaceuticals, INC. | $587.28 | 2023-2025 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $569.75 | 2019-2025 | Eylea Hd, Eylea |
| Alcon Vision LLC | $379.03 | 2019-2025 | Clareon, Hydrus Microstent |
| Novartis Pharmaceuticals Corporation | $358.86 | 2019-2021 | |
| Astellas Pharma US INC | $295.19 | 2024-2025 | Izervay |
| Sight Sciences, INC. | $273.48 | 2023-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $271.77 | 2019-2020 | |
| Horizon Therapeutics Plc | $223.53 | 2021-2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $184.14 | 2019-2021 | |
| Biotissue Holdings INC. | $160.94 | 2022 | |
| Glaukos Corporation | $145.58 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $113.88 | 2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $112.37 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $108.20 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| New World Medical,INC. | $107.01 | 2019 | |
| Biogen, INC. | $45.61 | 2022-2023 | |
| Alimera Sciences, INC. | $39.70 | 2024 | Iluvien, Yutiq |
| Abbvie INC. | $16.72 | 2024 | |
| Aerie Pharmaceuticals, INC. | $15.00 | 2019 | |
| Mallinckrodt Hospital Products INC. | $15.00 | 2022 | |
| Genentech USA, INC. | $13.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larisa Kayserman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.